<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/25A2E66E-80B7-4D07-BECC-29DCAC81C8FD"><gtr:id>25A2E66E-80B7-4D07-BECC-29DCAC81C8FD</gtr:id><gtr:name>Case Western Reserve University</gtr:name><gtr:address><gtr:line1>Dept of Mechanical &amp; Aero</gtr:line1><gtr:line2>Space Engineering</gtr:line2><gtr:line3>Cleveland</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8218E276-85FA-4CD5-86AA-232A830B5037"><gtr:id>8218E276-85FA-4CD5-86AA-232A830B5037</gtr:id><gtr:name>University of Texas at San Antonio</gtr:name><gtr:address><gtr:line1>One UTSA Circle</gtr:line1><gtr:line4>San Antonio</gtr:line4><gtr:line5>TX 78249-1644</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BAD30457-C7D8-47F9-82B2-BC7F94CBD295"><gtr:id>BAD30457-C7D8-47F9-82B2-BC7F94CBD295</gtr:id><gtr:name>Enzo Life Sciences</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/693AE96A-F252-4F6F-840C-685C4D1D0904"><gtr:id>693AE96A-F252-4F6F-840C-685C4D1D0904</gtr:id><gtr:name>University of Sherbrooke</gtr:name><gtr:address><gtr:line1>Boul</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E7910513-EA16-41B2-A0C0-7F49C936A4BF"><gtr:id>E7910513-EA16-41B2-A0C0-7F49C936A4BF</gtr:id><gtr:name>University of Wales</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>University Registry</gtr:line1><gtr:line2>King Edward VII Ave</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:postCode>CF10 3NS</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E7910513-EA16-41B2-A0C0-7F49C936A4BF"><gtr:id>E7910513-EA16-41B2-A0C0-7F49C936A4BF</gtr:id><gtr:name>University of Wales</gtr:name><gtr:address><gtr:line1>University Registry</gtr:line1><gtr:line2>King Edward VII Ave</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:postCode>CF10 3NS</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/25A2E66E-80B7-4D07-BECC-29DCAC81C8FD"><gtr:id>25A2E66E-80B7-4D07-BECC-29DCAC81C8FD</gtr:id><gtr:name>Case Western Reserve University</gtr:name><gtr:address><gtr:line1>Dept of Mechanical &amp; Aero</gtr:line1><gtr:line2>Space Engineering</gtr:line2><gtr:line3>Cleveland</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8218E276-85FA-4CD5-86AA-232A830B5037"><gtr:id>8218E276-85FA-4CD5-86AA-232A830B5037</gtr:id><gtr:name>University of Texas at San Antonio</gtr:name><gtr:address><gtr:line1>One UTSA Circle</gtr:line1><gtr:line4>San Antonio</gtr:line4><gtr:line5>TX 78249-1644</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BAD30457-C7D8-47F9-82B2-BC7F94CBD295"><gtr:id>BAD30457-C7D8-47F9-82B2-BC7F94CBD295</gtr:id><gtr:name>Enzo Life Sciences</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/693AE96A-F252-4F6F-840C-685C4D1D0904"><gtr:id>693AE96A-F252-4F6F-840C-685C4D1D0904</gtr:id><gtr:name>University of Sherbrooke</gtr:name><gtr:address><gtr:line1>Boul</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BB7119A5-BFFF-47E9-9660-C7FB4D649326"><gtr:id>BB7119A5-BFFF-47E9-9660-C7FB4D649326</gtr:id><gtr:firstName>Julian</gtr:firstName><gtr:surname>Sampson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A33F27B8-CB09-4F3A-B7AC-02FDCC1D8F24"><gtr:id>A33F27B8-CB09-4F3A-B7AC-02FDCC1D8F24</gtr:id><gtr:firstName>Alan</gtr:firstName><gtr:surname>Clarke</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7E584BFB-B045-40CA-AFC7-AD0CA13C8458"><gtr:id>7E584BFB-B045-40CA-AFC7-AD0CA13C8458</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Wynford Thomas</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4EB18518-01F4-4B98-A1C4-31D944CB87AC"><gtr:id>4EB18518-01F4-4B98-A1C4-31D944CB87AC</gtr:id><gtr:firstName>Ray</gtr:firstName><gtr:surname>Waters</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E3EC61A1-33C9-4D42-99E8-14162708A690"><gtr:id>E3EC61A1-33C9-4D42-99E8-14162708A690</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:otherNames>Huw</gtr:otherNames><gtr:surname>Reed</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/73B13B2D-8FDC-4EC5-B9FB-62975C166FFE"><gtr:id>73B13B2D-8FDC-4EC5-B9FB-62975C166FFE</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E87D366B-1DA0-432B-934C-5EC494851E22"><gtr:id>E87D366B-1DA0-432B-934C-5EC494851E22</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C9E84E69-2A45-4348-9C8B-19FB6204B740"><gtr:id>C9E84E69-2A45-4348-9C8B-19FB6204B740</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Kipling</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0301154"><gtr:id>103585BA-AEAC-4B25-AABB-F4C98730621B</gtr:id><gtr:title>Stress, DNA damage and disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0301154</gtr:grantReference><gtr:abstractText>The impact of defective DNA repair is seen in patients with xeroderma pigmentosum, who have very high incidences of skin cancer due to being unable to remove sunlight-induced DNA damage and in patients suffering with predispositions to colorectal and other cancers. Simply put, un-repaired DNA damage causes mutations which contribute to the incidences of genetic defects and to cancer. Hence DNA repair is crucial to reduce the incidence of harmful mutations.
This MRC co-operative award allows several research teams working on DNA repair, cell stress and cancer to benefit from core technologies that support all of them. One technology provides the ability to follow DNA repair proteins by tagging them with fluorescent factors to enable them to be detected in cells, so as we can see how they react to DNA damage. The other technology enables us to analyse DNA repair proteins via mass spectrometry to unravel their composition; this is the first step in understanding the structure of repair proteins so as we can determine how they interact with DNA in our cells to detect and remove DNA damage.</gtr:abstractText><gtr:technicalSummary>Little is known as to how DNA excision repair functions in DNA packaged as chromatin, be it in active or repressed domains, or in telomeres. Large complexes metabolizing DNA, such as those involved in transcription, require an intricate series of events to function productively in this environment. It is now evident that for transcription, different chromatin remodelling events alter the structural organization of different parts of the genome, and that some regions are arranged in domains, where specific types of remodelling can predominate. 
Large complexes involved in DNA repair require specific factors to operate in chromatin, and chromatin remodelling is intimately linked to the cancer process. How chromatin remodelling relates to repair, cell stress, cell ageing or tumourigenesis needs to be addressed. We wish to build on existing strengths in our areas of focus, especially nucleotide excision repair and mismatch repair so as to foster new collaborations to tackle these issues.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>394304</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Weatherall Institute of Molecular Medicine (WIMM)</gtr:department><gtr:description>NER, transcription and histone modifications at the PHO5 locus of yeast</gtr:description><gtr:id>D586FF81-B00C-4C3C-84F2-BD09169CE1EF</gtr:id><gtr:impact>We have discovered that despite the absence of nucleosomes in the PHO5 promoter transcription can inhibit NER in certain circumstances. We are currently examining the reasons for this.</gtr:impact><gtr:outcomeId>B63D471E1AF-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator, Peter McHugh, provided the strains and made substantial intellectual contributions to the project.</gtr:partnerContribution><gtr:piContribution>We used the strains provided to examine NER in exquisite detail at the PHO5 regulatory region under varying transcriptional states.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Case Western Reserve University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Biochemical Function of the Yeast GGNER Complex</gtr:description><gtr:id>D9ADB8A4-80A9-4F08-B65D-46BFCED62456</gtr:id><gtr:impact>JBC Paper 18996839
Work was also cited in a review by our collaborator</gtr:impact><gtr:outcomeId>ammMecEyN7h-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator trained one of our researchers in several key chromatin remodelling assays.</gtr:partnerContribution><gtr:piContribution>We uncovered the biochemical activities of the yeast GGNER complex in chromatin remodelling.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Enzo Life Sciences</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Generating Antibodies against Novel NER Components</gtr:description><gtr:id>5B12DBC9-AA99-4BA3-AF53-9F1FD41BD8E5</gtr:id><gtr:impact>EMBO J - 16675952
JBC Paper - 18996839</gtr:impact><gtr:outcomeId>pbDC14oHbdx-1</gtr:outcomeId><gtr:partnerContribution>Enzo Life Sciences have generated a number of key peptide antibodies raised against several NER factors.</gtr:partnerContribution><gtr:piContribution>We identified a number of novel NER factors and are using the newly generated antibodies to discover the functions of these proteins.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Texas</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>The Role of the Proteasome in Nucleotide Excision Repair</gtr:description><gtr:id>FA1B99E1-8998-4227-92A5-AE77C7E3281B</gtr:id><gtr:impact>EMBO J - 16675952
Roads to Rome review - 17150417</gtr:impact><gtr:outcomeId>cnUycr3dshc-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator provided a number of key strains and reagents necessary for our investigation into the role of the proteasome in NER.</gtr:partnerContribution><gtr:piContribution>We provided all of the expertise and reagents necessary for investigating the connection with nucleotide excision repair.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Molecular Medical Sciences Nottingham</gtr:department><gtr:description>NER and chromatin modifications in subtelomeric regions of yeast</gtr:description><gtr:id>F3DA50D0-4B31-411F-A00C-44A40779E89F</gtr:id><gtr:impact>We uncovered a role for Sir2 in suppressing UV induced H3 acetylation. All work was undertaken at Cardiff University by Yachuan Yu (MRC PD) and A Irizar (MRC PhD). A paper has been written and submitted.</gtr:impact><gtr:outcomeId>C3A8A814C6F-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator, Ed Louise, provided the strains.</gtr:partnerContribution><gtr:piContribution>We modified the strains substantially to examine how NER operated on the URA3 gene when relocated to repressed versus transcriptionally active subtelomeric regions.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Diego (UCSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pathology</gtr:department><gtr:description>Studies on Global Genome Repair in Yeast</gtr:description><gtr:id>3DB0EDA3-5413-47BD-AD25-B04894E0310D</gtr:id><gtr:impact>EACR Cancer Researcher Award International Patent granted
Publications 18996839 17150417 16675952</gtr:impact><gtr:outcomeId>rMPaCMpHSzo-1</gtr:outcomeId><gtr:partnerContribution>Our research demonstrated specific biochemical activities of the GGNER complex which were then investigated further by examining in vivo DNA repair assays.</gtr:partnerContribution><gtr:piContribution>Certain DNA repair assays for interpretation of specific biochemical data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sherbrooke</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>How Rad4 and Rad34 contribute to rDNA repair in relation to chromatin structure</gtr:description><gtr:id>1C757085-F9E1-49CA-A69F-AB027CCB72BA</gtr:id><gtr:impact>We were able to uncover exactly where there were separate roles for the Rad4 and its homologous Rad34 NER protein in NER (see paper 18936173).</gtr:impact><gtr:outcomeId>D8A9BCFEC23-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator, Antonio Conconi, developed the method to separate the repressed and active copies of the rDNA genes and sent us samples from UV irradiated cells.</gtr:partnerContribution><gtr:piContribution>We applied the technology that we had developed to examine NER and nucleotide resolution in the UV irradiated cell samples provided by our collaborator.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Diego (UCSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pathology</gtr:department><gtr:description>Roles of Rad16 in modifying chromatin structure for NER</gtr:description><gtr:id>E6B81EE3-815A-4846-A71F-F7E7F4C76325</gtr:id><gtr:impact>PNAS publication (pubmed ref) EMBO Reports last year (ref) Three papers in draft form 1 - The role of Rad16 in facilitating histone acetylation post UV submitting to Molecular Cell 2 - The role of histone H3 and H4 acetylation post UV in facilitating NER in subtelomeric regions (under revision for Nucleic Acids Research) 3 - A method to examine DNA damage at high resolution in entire genomes (submitted to Nature Methods)</gtr:impact><gtr:outcomeId>D0C4CD61F78-1</gtr:outcomeId><gtr:partnerContribution>My collaborator Simon Reed and myself have identified a key role for Rad16 in facilitating post UV histone acetylation to facilitate efficient NER. Rad16 determines the recruitment post UV of the histone acetyltransferase Gcn5 which is a key factor in enabling efficient NER in parts of the yeast genome.</gtr:partnerContribution><gtr:piContribution>My research team set the ground work for this collaboration by identifying a role for Gcn5 in efficient NER, by developing the assays we employed to examine NER at nucleotide resolution an by showing that hyperacetylated regions did not require Rad16 for NER.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cancer Research UK London Research Institute (LRI)</gtr:department><gtr:description>A role for Mec1 in NER</gtr:description><gtr:id>0D63B718-15CF-4414-A8EE-B517ED48CB24</gtr:id><gtr:impact>We showed that there was a role for Mec1 in phosphorylation in governing both TC-NER and GG-NER (see paper 18936173).</gtr:impact><gtr:outcomeId>60C4762C4EC-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator, Jesper Svejstrup, had suspected that there was a role for Mec1 in NER.</gtr:partnerContribution><gtr:piContribution>We examined this by first housing his PhD student, Michael Taschner, who worked with Yumin Teng (our MRC PD) to employ technology we had developed and then by analysing samples at both labs.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>28806612-24B8-4D44-8386-DAFB76A54C82</gtr:id><gtr:impact>Published on line lay information for research undertaken in the group.

Invitations to speak at a number of charity fund raising events including Rotary Club, Cancer Research Wales and Probus.</gtr:impact><gtr:outcomeId>BnnHJCPvQpm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit by Wales Assembly Members - inc First Minister</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>C0AE655D-EDC5-4B5C-90FE-EF95453249BD</gtr:id><gtr:impact>Hosted an informal visit by the First Minister to inform him of Cancer Research activities in Biosciences and hosted a second informal visit by the First Minister to introduce the Cardiff CRUK Cancer Centre and the WAG funded PET centre.

Continued interest/discussion with WAG re-enhancement/investment in cancer activity within Cardiff.</gtr:impact><gtr:outcomeId>11DC8AB8A99</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture - Royal Institute of South Wales</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>BE121D89-6077-47A0-AC1A-A5DC8F47C697</gtr:id><gtr:impact>I described how DNA repair is required to reduce cancer and mutational risk, how one can study this highly conserved process in model organisms. I then went on to outline how our contributions employing yeast as a model have unravelled how the genome compacted as chromatin is accessed for repair and restored to its pre-damaged status. I ended by describing the implications of our research on human health and cancer risk.

Considerable public interest and many questions.</gtr:impact><gtr:outcomeId>BEB3935851D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Permanent AudioVisual Display at &quot;Frontiers &quot;- at National Waterfront Museum, Swansea</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>33C9E36C-336E-4962-9726-95DBE41402B4</gtr:id><gtr:impact>Development of a permanent dispaly for the museum as an effective method of reaching out to thousands of visitors - allowing them to investigate Welsh upcoming innovations in the Frontiers gallery of the national Museum - in particular cancer diagnostic technologies. http://www.museumwales.ac.uk/en/swansea/frontiers/

A highly effective method of reaching out to thousands of visitors, school parties and officials.</gtr:impact><gtr:outcomeId>E184859142C</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.museumwales.ac.uk/en/swansea/</gtr:url><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lectures</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>6293F332-C2ED-4CC8-80D6-A05F2B35D23F</gtr:id><gtr:impact>Public lectures to local groups including various charity organisations, e.g. Rotary Club.

Donations to Cancer Research Wales.</gtr:impact><gtr:outcomeId>QG52XF3Pi31</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosting Visits - Cancer Charity Supporters</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>85D4A179-82E5-4829-A815-BB4B02410AE0</gtr:id><gtr:impact>We hosted visits by cancer charity supporters so that the could see how their donations were being put to work.

The most positive outcome has been direct financial support either to the University or to a Charity.</gtr:impact><gtr:outcomeId>544326592E7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Policy - COMARE Report on Sunbed Legislation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9CC587F7-D68C-4C69-853A-7E0B41B126C0</gtr:id><gtr:impact>Here I used our findings to suggest further investigations into how risk of radiation exposure is measured and perceived.

Two high profile interviews on BBC breakfast television to increase public awareness of the risks associated with sunbed use and sunbathing.</gtr:impact><gtr:outcomeId>BE0A4CDDE8E</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Podcasts for CRUK</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>060ABD4D-339D-4E88-91D2-B39AFB6397D0</gtr:id><gtr:impact>The first podcast was regarding a publication that appeared in Nature Genetics about the identification of a novel therapeutic target for colorectal cancer. The second was regarding the award of the new Cardiff CRUK cancer centre.

We did receive some direct public donations, we were also featured on both ITV and BBC news.</gtr:impact><gtr:outcomeId>ACB514C2CB6</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture - The RAFT Institute, Mount Vernon Hospital</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>37736BE1-EEA5-416E-A1D6-BF7B776663C6</gtr:id><gtr:impact>I was invited to present our new technology for examining DNA damage at high resolution in entire genomes with a view to setting up collaborations to examine UV damage in skin tissue.

None as yet.</gtr:impact><gtr:outcomeId>2E35E8F51D3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUk funding (Validating methylation sensing proteins as therapeutic targets)</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>548DC746-30D0-4CDF-8FCD-6A06F9B0E7EA</gtr:id><gtr:outcomeId>D26CA80388C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NISCHR Cancer Genetics BRU Award (The development of novel methods for translational studies in cancer genetics)</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Health and Care Research Wales</gtr:fundingOrg><gtr:id>CDC4B5F3-C960-4D5A-A90F-55A4238A5509</gtr:id><gtr:outcomeId>pTBSZnos9FA0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>26000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Studentship - Determining the non-proteolytic function of a novel E3 ubiquitin ligase in NER</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8C30FEAA-0B13-49EC-9EAE-C06748806D0A</gtr:id><gtr:outcomeId>iWYU8f4JFTG0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project award</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>23B95F0D-E950-48DD-8CA8-0BEDEA9B6CF7</gtr:id><gtr:outcomeId>kUkLhBMifZS0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>53000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Studentship - Investigating the role of ABF1 binding in nucleotide excision repair</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>610C07BC-7EF7-4C4B-9FA9-9AC3AC990B17</gtr:id><gtr:outcomeId>gLbu2xccmxc0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Investigating the immediate and therapeutic effects of MEK inhibition and P13K inhibition in a genetically relevant autchthonous model of human colorectal cancer</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Tenovus</gtr:fundingOrg><gtr:id>43E837AE-9C67-478D-B9E0-3EFA89C67FD8</gtr:id><gtr:outcomeId>434DBA63C610</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK funding (The Wnt pathway in colorectal disease: Validation of novel targets and intervention strategies and the refinement of existing models)</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>992C2A65-DE8D-44B4-B78E-22244F0261AA</gtr:id><gtr:outcomeId>FE8D8BDDFD30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>220000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK funding (Investigating the PI3 kinase and Ki-Ras pathway interactions in colorectal cancer: new models and drug validation)</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>A2F5546D-0B4A-43F3-8006-7049084A45C6</gtr:id><gtr:outcomeId>FBD29EAB5F80</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1654640</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wales Gene Park</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>Health and Care Research Wales</gtr:fundingOrg><gtr:id>FD4A83C5-0F09-4CC4-8E8B-02476397EA0A</gtr:id><gtr:outcomeId>26ABC33DEFE0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>240000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK funding (Analysis of in vivo tumour suppression mediated through Lkb1 and Pten)</gtr:description><gtr:end>2010-06-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>0E6ABFA5-6FA3-4FDA-AAB2-50ABEC70CCD9</gtr:id><gtr:outcomeId>3F528561B290</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>University of Cardiff College of Medicine, Lord Merthyr Scholarship</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>Cardiff University</gtr:fundingOrg><gtr:id>493EA158-359D-40B9-AC06-35B9FBE09487</gtr:id><gtr:outcomeId>ntBMseJv6gM0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>43000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Epigenetics and Cancer</gtr:description><gtr:end>2010-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>A4EA08B6-855C-4AFA-BA69-4472289555D7</gtr:id><gtr:outcomeId>274B10698AE0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (Development of new agents for colorectal cancer (CRC) using genetically defined autochthonous models)</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A7ED5871-60C5-45E5-90A1-86637ACF3EAF</gtr:id><gtr:outcomeId>382723FC7AC0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1423468</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EP/F040954/1 EPSRC Basic Technology Programme (Intracellular Biophotonic Nanoswitches)</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/F040954/1</gtr:fundingRef><gtr:id>9E15A91C-0041-4554-886F-A7699F6B6099</gtr:id><gtr:outcomeId>AD7979193A70</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>VIP Award</gtr:description><gtr:end>2007-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>97074309-32BD-4B30-AAFA-3029C8760E70</gtr:id><gtr:outcomeId>nFt8KNszzLj0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Infrastructure Award to Establish Structural Biology as a Discipline at Cardiff</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Cardiff University</gtr:fundingOrg><gtr:id>736094AF-97C6-4A49-8045-AC85010C9823</gtr:id><gtr:outcomeId>qVCbFoawVqq0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The method enables us to examine DNA damage and repair for entire genomes on microarrays and to determine how chromosomes are modified to facilitate the functioning of repair.</gtr:description><gtr:grantRef>G0301154</gtr:grantRef><gtr:id>7B896E39-3425-4189-AC22-652C6A95C7B8</gtr:id><gtr:impact>The clinical sector have noted that our technology can be applied to examine the reaction and fate of anti cancer therapies such cisplatin in patients undergoing therapy.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>D2E030A81FE</gtr:outcomeId><gtr:patentId>GB2463197</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Technology to examine DNA damage and repair</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Published Earliest priority date 29/01/2008 International filing date 29/01/2009 Field of the Invention: Cell biology and drug screening. The invention relates to the use of a cell culture microtrench having dimensions which allow attachment of cells to the surface of the trench and constrain the location and behaviour of cells for analytical advantage. The invention also relates to such a microtrench, arrays of such trenches with varying dimensions to provide for selection of optimal assay characteristics for a user-defined purpose, and arrays of trenches with the same dimensions to facilitate the scaling up and efficiency of a given assay. The trenches and/or arrays can be readily incorporated into convenient methods of cellular analysis in research, diagnostics and screening assays. WO2009095666 (A1)</gtr:description><gtr:grantRef>G0301154</gtr:grantRef><gtr:id>26989144-A418-46BC-8BA5-546160D7F689</gtr:id><gtr:impact>Expolitation partnership currently underway</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>8F12563B615</gtr:outcomeId><gtr:patentId>WO2009095666</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Microtrench - a novel device for the analysis of cell proliferation</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>COMARE on Sunbed Legislation</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>1EA7B65C-BE56-4705-BF8F-28AF786AAB98</gtr:id><gtr:impact>We have advised that unmanned sunbeds are banned, that manned parlours are only available to those over 18 and that they are staffed by individuals who advise clientele with respect to the risks.</gtr:impact><gtr:outcomeId>B04D46E8591</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Training of UK based genetic toxicologists</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>86A98369-64D0-4CCB-9D55-F8DE5E692DF3</gtr:id><gtr:impact>Continuous development for professional genetic toxicologists in UK industry.</gtr:impact><gtr:outcomeId>BMMQVjvPNvi</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Working Group for Improved Radiation Therapy</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>490D3673-6708-489E-9666-42C78A0A7782</gtr:id><gtr:impact>The working group aims to improve the delivery of radiotherapy in the UK.</gtr:impact><gtr:outcomeId>ACxWVkkcHci</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Chairman of UK Genome Stability Network</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>4E84B5AF-8A66-418F-9E28-C10464BB0CC3</gtr:id><gtr:impact>Provides a forum for training and development of UK based students and post docs working in the field of genome stability.</gtr:impact><gtr:outcomeId>iojs2ZFmFuo</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Novel antibodies against two key NER proteins</gtr:description><gtr:id>D7F5CA05-9DB4-4ABB-98FF-2DCF7BB8B0FA</gtr:id><gtr:impact>EMBO J Paper on Rad23/4 function in NER.</gtr:impact><gtr:outcomeId>NU7fcikpuFK</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Yeast Rad4 antibody, Yeast Rad33 antibody</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Novel tools for detecting genome wide DNA damage and repair at high resolution throughout genomes</gtr:description><gtr:id>412CA358-3A03-45A4-A370-2954E37482F3</gtr:id><gtr:impact>NAR Paper 2010
IP published 2009
Collaboration with Agilent Technologies and KTP awarded to develop the method for gentox testing.
NISCHR BRU grant.</gtr:impact><gtr:outcomeId>ocSGPZLM1bb</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Omics method for detection of DNA damage and repair</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Newly identified E3 ligase function of the GGNER complex</gtr:description><gtr:id>1A3DB0D1-A730-4FB0-B2D0-6E9CED10B3FB</gtr:id><gtr:impact>Papers EMBO J - 16675952</gtr:impact><gtr:outcomeId>bgRQY3akCgq</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GGNER Complex Purification and Characterisation</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A novel cell lineage database for generation associated phenotypic behavior in cell-based assays. Public release 2007: PMID: 17387278</gtr:description><gtr:id>FADA59DE-C7B4-4B56-B210-758C8D1F4288</gtr:id><gtr:impact>The database is no in use for developing cel-cycle models with systems biology groups in Warwick and Swansea. The core data has laid the foundation for a two-site EPSRC bid for platform funding.</gtr:impact><gtr:outcomeId>240706EED2E</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ProgeniDB</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:url>http://europepmc.org/abstract/MED/17387278</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Gene expression profiles for UV regulated genes by a novel E3 ubiquitin ligase</gtr:description><gtr:id>52EE30D3-C8C2-41A4-8406-0C99D48C0A1B</gtr:id><gtr:impact>EMBO J 2006 Paper and PhD Thesis 2010</gtr:impact><gtr:outcomeId>mhsRUZ6oGbX</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Expression arrays for UV induced gene transcription</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Novel strains to investigate function of the GGNER proteins in yeast</gtr:description><gtr:id>A9CF9F95-92B8-4123-8DB5-5C5769D31F9E</gtr:id><gtr:impact>Papers JBC - 18996839 EMBO J - 16675952</gtr:impact><gtr:outcomeId>jcLoEtfU97L</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GGNER Complex Function in Vivo</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We report a fluorescence lifetime imaging technique that uses the time integrated response to a periodic optical excitation, eliminating the need for time resolution in detection. This stroboscopic technique offers lifetime based imaging at video rates with standard CCD cameras and has application in probing millisecond cell dynamics and in high throughput imaging assays.</gtr:description><gtr:id>567198A5-314E-4EAB-B974-133B48F31B40</gtr:id><gtr:impact>Has underpinned a PhD studentship and MRC discipline hopping Fellowship. Currently in use and development in concert with a newly established collaborative group with Swansea University MNC.</gtr:impact><gtr:outcomeId>E0F84BF029D</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Stroboscopic fluorescence lifetime imaging</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed and characterised the nature of ABCG2-associated resistance to Hoechst 33342 and the model anticancer drug topotecan in a murine cell model with constitutive expression of side population characteristics. This is the first stable cell line for defining the 'side population' phenotype for incorporation into flow cytometric assays of stem cell populations. The details have been released in 2009 (PMID: 19802874)</gtr:description><gtr:id>F81E1680-78E8-49AA-B224-BAB0A9CA3632</gtr:id><gtr:impact>Public disclosure only in 2009 (PMID: 19802874)</gtr:impact><gtr:outcomeId>52B5ED66C97</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Novel mammalian cell line for assessing the impact of drug transporters in anticancer drug resistance</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19802874</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The method enables us to examine DNA repair for entire genomes on microarrays and to determine how chromosomes are modified to facilitate the functioning of repair.</gtr:description><gtr:id>78D3159C-C809-4DA0-9325-8453C8074377</gtr:id><gtr:impact>There is currently a patent in progress - patent number 0712584.2.</gtr:impact><gtr:outcomeId>4C7161BA39E</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Technology to examine DNA  damage repair</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Bioinformatic tools for normalising and peak calling for the detection of UV induced DNA damage by Chip CHip</gtr:description><gtr:id>DBA1B008-3A11-4EBC-9DAF-DCF424FB7198</gtr:id><gtr:impact>NAR paper 2010</gtr:impact><gtr:outcomeId>XwdnwCmsTPk</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Tools for analysing chip chip data for DNA damage induction</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have generated a series of novel mouse models of human colorectal disease. These include mice mutant for Apc and Pten (2009), mice mutant for Lkb-1 (2009), mice mutant for K-ras and Apc (2007). All of these models, which are aimed at sequentially replicating the stages of human colorectal cancer have been provided freely to other research groups.</gtr:description><gtr:id>CF945D08-0380-4185-BCDA-393CFF264792</gtr:id><gtr:impact>Virtually all new activity in the group is based around the generation of these novel models, hence we have initiated collaborations as detailed in the collaborations section. Also new grant revenue as detailed in period was dependent upon the development of these models.</gtr:impact><gtr:outcomeId>7185218D88D</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Generated Series of Novel Mouse Models of Human Colorectal Disease</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>ABD4CA2A-ECEC-4864-A5F7-3D5BBAA325C4</gtr:id><gtr:title>Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2cb48f0baf87eb3234ab8b056897ed0c"><gtr:id>2cb48f0baf87eb3234ab8b056897ed0c</gtr:id><gtr:otherNames>Davies DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>0222FBA83E6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B6DFAF1-1EEC-49E8-B77F-69D83A801E12</gtr:id><gtr:title>Kaiso-deficient mice show resistance to intestinal cancer.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6d9e771756655bc7abd0967e5260154"><gtr:id>e6d9e771756655bc7abd0967e5260154</gtr:id><gtr:otherNames>Prokhortchouk A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>BD2AD0EEAF6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1B5A865-2F68-4303-BBA4-DA617FA3E5C6</gtr:id><gtr:title>MBD2 is required for correct spatial gene expression in the gut.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/465d2b5dbf85f949bd8f400758210819"><gtr:id>465d2b5dbf85f949bd8f400758210819</gtr:id><gtr:otherNames>Berger J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>87F6A1A839B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D196E5D-4A7C-4E21-AC12-B55FD557423E</gtr:id><gtr:title>Stroboscopic fluorescence lifetime imaging.</gtr:title><gtr:parentPublicationTitle>Optics express</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f58c2b90ee5c4560258c647b25db293c"><gtr:id>f58c2b90ee5c4560258c647b25db293c</gtr:id><gtr:otherNames>Holton MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1094-4087</gtr:issn><gtr:outcomeId>AE323F8968F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11BD794B-5868-4F77-8A1C-2606DDABBEBE</gtr:id><gtr:title>Cytomics and drug development.</gtr:title><gtr:parentPublicationTitle>Cytometry. Part A : the journal of the International Society for Analytical Cytology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/988a9bf4602ba26684ef8f41fe1b3fc6"><gtr:id>988a9bf4602ba26684ef8f41fe1b3fc6</gtr:id><gtr:otherNames>Smith PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1552-4922</gtr:issn><gtr:outcomeId>7A8438AE251</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>948BCA7E-0879-44AE-87BE-48F151759C0F</gtr:id><gtr:title>Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications.</gtr:title><gtr:parentPublicationTitle>Advanced drug delivery reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/950b692ffbce667a95b537bea00c5b25"><gtr:id>950b692ffbce667a95b537bea00c5b25</gtr:id><gtr:otherNames>Kumar LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0169-409X</gtr:issn><gtr:outcomeId>9A3EC5C0774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE48FFB7-08B2-412E-B85A-8E142B4DA9AC</gtr:id><gtr:title>Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41e47b79ffd5db2b77144545ab917129"><gtr:id>41e47b79ffd5db2b77144545ab917129</gtr:id><gtr:otherNames>Dallosso AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>D3B4DC5DBCC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A0026DB-BA6A-4EA3-9FBD-BE61B25812B9</gtr:id><gtr:title>Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c29195d5b62c41ae4af17a583b36483"><gtr:id>1c29195d5b62c41ae4af17a583b36483</gtr:id><gtr:otherNames>Sansom OJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>DECE3CCCF8E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>231AA505-E232-45AA-BC2B-58E0BD14EEFE</gtr:id><gtr:title>B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a42426eb57ccd45825165b8b4e6f1eac"><gtr:id>a42426eb57ccd45825165b8b4e6f1eac</gtr:id><gtr:otherNames>Reed KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>7D1E1B6FA11</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F06DA3D6-B07D-4433-AA06-B1E929A58273</gtr:id><gtr:title>Crypt stem cells as the cells-of-origin of intestinal cancer.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0cf2845d4af93eebb7e89ea40622421"><gtr:id>c0cf2845d4af93eebb7e89ea40622421</gtr:id><gtr:otherNames>Barker N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>TWBzu3LdKiF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A2B8D43-6891-40BC-A755-DFE790608D56</gtr:id><gtr:title>Puma: mauling the intestinal crypt.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a815f035043115ade2a0578c8b56034e"><gtr:id>a815f035043115ade2a0578c8b56034e</gtr:id><gtr:otherNames>Clarke AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>AE8FC2377B8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B38E03C3-C3A5-41A4-BC49-8F92E7173AFA</gtr:id><gtr:title>Nucleotide excision repair and the ubiquitin proteasome pathway--do all roads lead to Rome?</gtr:title><gtr:parentPublicationTitle>DNA repair</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c04de91f45c08e82df13b8faa64fa36d"><gtr:id>c04de91f45c08e82df13b8faa64fa36d</gtr:id><gtr:otherNames>Reed SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1568-7856</gtr:issn><gtr:outcomeId>gmpAbiaebME</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85FBF21C-F67B-4139-AD56-9EDA66033010</gtr:id><gtr:title>Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f286118b933bfd5db6e8681bfe613251"><gtr:id>f286118b933bfd5db6e8681bfe613251</gtr:id><gtr:otherNames>Duce JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>4DED6613F7F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6081DDE0-7DC3-4A56-8DB8-6F055B43AB28</gtr:id><gtr:title>PPARdelta status and mismatch repair mediated neoplasia in the mouse intestine.</gtr:title><gtr:parentPublicationTitle>BMC cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a42426eb57ccd45825165b8b4e6f1eac"><gtr:id>a42426eb57ccd45825165b8b4e6f1eac</gtr:id><gtr:otherNames>Reed KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1471-2407</gtr:issn><gtr:outcomeId>3F671F90257</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06ABF16A-5771-41BA-8F5B-408AC918AF65</gtr:id><gtr:title>A role for SUMO in nucleotide excision repair.</gtr:title><gtr:parentPublicationTitle>DNA repair</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a131175e656930c7e0182c184f35db01"><gtr:id>a131175e656930c7e0182c184f35db01</gtr:id><gtr:otherNames>Silver HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1568-7856</gtr:issn><gtr:outcomeId>KBTbU3G4pbR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F893052E-3097-49E1-869F-AAF467F3DBA0</gtr:id><gtr:title>Human basal cell carcinoma tumor-initiating cells are resistant to etoposide.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea90bdd0f7f8ae2987d6db040b73a061"><gtr:id>ea90bdd0f7f8ae2987d6db040b73a061</gtr:id><gtr:otherNames>Colmont CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>pm_15247_27_24025552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19596360-9655-4B85-A30A-76ECE1B2887C</gtr:id><gtr:title>Guidelines for the clinical management of familial adenomatous polyposis (FAP).</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48e760e6709b308d5b263d1c802d2f41"><gtr:id>48e760e6709b308d5b263d1c802d2f41</gtr:id><gtr:otherNames>Vasen HF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>FDE5553D080</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78D48585-AA7D-4593-886A-0BF4CE2ABF71</gtr:id><gtr:title>Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ed66c459e958a349c48173f95ced08f"><gtr:id>9ed66c459e958a349c48173f95ced08f</gtr:id><gtr:otherNames>Nielsen M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>290CE632ECE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D34D8F65-5BB9-496F-B8F6-319A77002D28</gtr:id><gtr:title>A coupled drug kinetics-cell cycle model to analyse the response of human cells to intervention by topotecan.</gtr:title><gtr:parentPublicationTitle>Computer methods and programs in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cf2e301e45b55d8efe42808a2786a92"><gtr:id>8cf2e301e45b55d8efe42808a2786a92</gtr:id><gtr:otherNames>Chappell MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0169-2607</gtr:issn><gtr:outcomeId>A64A9FDD34C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6812EFE3-D63C-45C5-A2F7-A9FEACC1BD2D</gtr:id><gtr:title>Impact of overexpression of metallothionein-1 on cell cycle progression and zinc toxicity.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Cell physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/988a9bf4602ba26684ef8f41fe1b3fc6"><gtr:id>988a9bf4602ba26684ef8f41fe1b3fc6</gtr:id><gtr:otherNames>Smith PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0363-6143</gtr:issn><gtr:outcomeId>08B894F94DF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>223D45F4-841E-4953-AD92-DADCB8AE5398</gtr:id><gtr:title>Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer).</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48e760e6709b308d5b263d1c802d2f41"><gtr:id>48e760e6709b308d5b263d1c802d2f41</gtr:id><gtr:otherNames>Vasen HF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>10B5F807DC5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15ECE2C9-7D6B-4C55-8FC5-4240BD5DEE1E</gtr:id><gtr:title>The APC Variant p.Glu1317Gln predisposes to colorectal adenomas by a novel mechanism of relaxing the target for tumorigenic somatic APC mutations.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41e47b79ffd5db2b77144545ab917129"><gtr:id>41e47b79ffd5db2b77144545ab917129</gtr:id><gtr:otherNames>Dallosso AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>B3D6D75F1DD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9492AE0-2A1D-4F2D-B5A6-C48D60745EFC</gtr:id><gtr:title>53BP1 deficiency in intestinal enterocytes does not alter the immediate response to ionizing radiation, but leads to increased nuclear area consistent with polyploidy.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a815f035043115ade2a0578c8b56034e"><gtr:id>a815f035043115ade2a0578c8b56034e</gtr:id><gtr:otherNames>Clarke AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>63A1F11FC2D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B59512D0-B0B7-4963-A9B6-40A67C0162FD</gtr:id><gtr:title>Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6ff025bba024246dc0c6a993bd46a23"><gtr:id>a6ff025bba024246dc0c6a993bd46a23</gtr:id><gtr:otherNames>Buchert M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>DjAgxk3gcFq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7BBD43E-8268-4F32-8FAF-384C138B79B9</gtr:id><gtr:title>Functional genome-wide analysis: a technical review, its developments and its relevance to cancer research.</gtr:title><gtr:parentPublicationTitle>Recent patents on DNA &amp; gene sequences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2ada29f8204721d18776f1a0267273d"><gtr:id>d2ada29f8204721d18776f1a0267273d</gtr:id><gtr:otherNames>Powell JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1872-2156</gtr:issn><gtr:outcomeId>pm_15247_27_23862717</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A79F47C-2DD1-4ACD-9B85-FA7850A658CC</gtr:id><gtr:title>Identification of a region required for TSC1 stability by functional analysis of TSC1 missense mutations found in individuals with tuberous sclerosis complex.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36b4117389050695167929e1a2b26211"><gtr:id>36b4117389050695167929e1a2b26211</gtr:id><gtr:otherNames>Mozaffari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>64FA24B3453</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8111829-4EC4-45B9-92C5-E37171740EC7</gtr:id><gtr:title>A limited role for p53 in modulating the immediate phenotype of Apc loss in the intestine.</gtr:title><gtr:parentPublicationTitle>BMC cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a42426eb57ccd45825165b8b4e6f1eac"><gtr:id>a42426eb57ccd45825165b8b4e6f1eac</gtr:id><gtr:otherNames>Reed KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2407</gtr:issn><gtr:outcomeId>481879B3767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EE13851-ABCA-4DF5-B2B2-38BBFD372D36</gtr:id><gtr:title>Fibroblast dysfunction is a key factor in the non-healing of chronic venous leg ulcers.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/150a11671304835d89886ac02acc0b56"><gtr:id>150a11671304835d89886ac02acc0b56</gtr:id><gtr:otherNames>Wall IB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>289F96F4C32</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35299849-9DCE-48CD-A367-ABFA89E302D2</gtr:id><gtr:title>Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2543dbb58ba9e251f81f2b79f9c78fc9"><gtr:id>2543dbb58ba9e251f81f2b79f9c78fc9</gtr:id><gtr:otherNames>Petrova TV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>ACAE123DE12</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40227C13-5F5E-4243-B61F-2F390B66B5BE</gtr:id><gtr:title>Lkb1 deficiency causes prostate neoplasia in the mouse.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b00ac6b255b6a6a45e6f96836f50c1bc"><gtr:id>b00ac6b255b6a6a45e6f96836f50c1bc</gtr:id><gtr:otherNames>Pearson HB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>145E5EF508C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>404F81B9-E0A7-4F05-81A8-BDC06EFAB9FB</gtr:id><gtr:title>Intestinal homeostasis and neoplasia studied using conditional transgenesis.</gtr:title><gtr:parentPublicationTitle>Expert review of anticancer therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b8b22ba717051d5fce9020b8322f814"><gtr:id>7b8b22ba717051d5fce9020b8322f814</gtr:id><gtr:otherNames>Marsh V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1473-7140</gtr:issn><gtr:outcomeId>A7253EDA568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00D72785-40B2-4D45-86CA-2CB784B8E93E</gtr:id><gtr:title>Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e31bb2fbe0f7780b80d48084f8052d1"><gtr:id>9e31bb2fbe0f7780b80d48084f8052d1</gtr:id><gtr:otherNames>Greenow KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>GzwPLXgVqet</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4496717-A258-4168-8656-0CF619541B4B</gtr:id><gtr:title>Nucleotide excision repair in chromatin: damage removal at the drop of a HAT.</gtr:title><gtr:parentPublicationTitle>DNA repair</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c04de91f45c08e82df13b8faa64fa36d"><gtr:id>c04de91f45c08e82df13b8faa64fa36d</gtr:id><gtr:otherNames>Reed SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1568-7856</gtr:issn><gtr:outcomeId>abuRiy9U3VF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB282C28-2DEA-4454-93F1-06B9080FCF96</gtr:id><gtr:title>Development of FRET-based assays in the far-red using CdTe quantum dots.</gtr:title><gtr:parentPublicationTitle>Journal of biomedicine &amp; biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ef5565d5631834cc791d4c9d5bc68cc7"><gtr:id>ef5565d5631834cc791d4c9d5bc68cc7</gtr:id><gtr:otherNames>Chong EZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1110-7243</gtr:issn><gtr:outcomeId>42DE23E6014</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74DCB372-B99D-4E04-9F7D-48F072F27521</gtr:id><gtr:title>Cytomics and cellular informatics--coping with asymmetry and heterogeneity in biological systems.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/988a9bf4602ba26684ef8f41fe1b3fc6"><gtr:id>988a9bf4602ba26684ef8f41fe1b3fc6</gtr:id><gtr:otherNames>Smith PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn><gtr:outcomeId>269368928D4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B4C295B-24D6-47E0-B709-52713F3220F0</gtr:id><gtr:title>Time-lapse microscopy approaches to track cell cycle progression at the single-cell level.</gtr:title><gtr:parentPublicationTitle>Current protocols in cytometry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc9bf4ad44c00ec105222a20aed4054e"><gtr:id>bc9bf4ad44c00ec105222a20aed4054e</gtr:id><gtr:otherNames>Errington RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1934-9297</gtr:issn><gtr:outcomeId>B09416CD8CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D77633CF-7245-4C2D-A6C9-25BB2CD5A6E2</gtr:id><gtr:title>Liver zonation occurs through a beta-catenin-dependent, c-Myc-independent mechanism.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fee9827038984fed295fc10d577e26d"><gtr:id>5fee9827038984fed295fc10d577e26d</gtr:id><gtr:otherNames>Burke ZD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>ZrM8ETWR9KB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E17CDF3-7253-4EC6-9E97-186FBDEF58C6</gtr:id><gtr:title>K-ras and Wnt signaling synergize to accelerate prostate tumorigenesis in the mouse.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b00ac6b255b6a6a45e6f96836f50c1bc"><gtr:id>b00ac6b255b6a6a45e6f96836f50c1bc</gtr:id><gtr:otherNames>Pearson HB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>43F9E9B1EE0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B16E7D6C-A713-4EF9-B954-F3C24768DBC7</gtr:id><gtr:title>Deficiency of Mbd2 attenuates Wnt signaling.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd8dab3c604a82336c7b97464f237af7"><gtr:id>dd8dab3c604a82336c7b97464f237af7</gtr:id><gtr:otherNames>Phesse TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>2483EC54355</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>536B98EA-9C65-4C35-9F48-FE6B75820B74</gtr:id><gtr:title>Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b8b22ba717051d5fce9020b8322f814"><gtr:id>7b8b22ba717051d5fce9020b8322f814</gtr:id><gtr:otherNames>Marsh V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>FB0F02808AC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1598E19E-508F-4E08-9C4C-F129239D2CE4</gtr:id><gtr:title>Myc deletion rescues Apc deficiency in the small intestine.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c29195d5b62c41ae4af17a583b36483"><gtr:id>1c29195d5b62c41ae4af17a583b36483</gtr:id><gtr:otherNames>Sansom OJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>02090161BAE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22E0F670-BBE9-4312-97B8-0794FDCE8421</gtr:id><gtr:title>Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38alpha(MAPK) inhibitors in Werner syndrome cells.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e652d93fb2ebe4adce6078cb4fe2f70c"><gtr:id>e652d93fb2ebe4adce6078cb4fe2f70c</gtr:id><gtr:otherNames>Davis T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0960-894X</gtr:issn><gtr:outcomeId>43A9A217C09</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75F1483F-4A34-4B5A-911A-EE118975162B</gtr:id><gtr:title>Loss of Indian Hedgehog activates multiple aspects of a wound healing response in the mouse intestine.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98f1f19a7f209d2e47e4757c0983ff35"><gtr:id>98f1f19a7f209d2e47e4757c0983ff35</gtr:id><gtr:otherNames>van Dop WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>mmC3RurphWD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FC400A9-7894-4913-84AE-CE98A4BF4A2F</gtr:id><gtr:title>Cyclin D1 overexpression permits the reproducible detection of senescent human vascular smooth muscle cells.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38e146696b1fae75e97d6a97917e28c2"><gtr:id>38e146696b1fae75e97d6a97917e28c2</gtr:id><gtr:otherNames>Burton DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>B9E1D988A27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F37AFC0-BE92-4C3A-B8B6-F10976ED790C</gtr:id><gtr:title>Murine models of intestinal cancer: recent advances.</gtr:title><gtr:parentPublicationTitle>DNA repair</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65112392c3d9e1886bf9783483531a20"><gtr:id>65112392c3d9e1886bf9783483531a20</gtr:id><gtr:otherNames>Shaw P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1568-7856</gtr:issn><gtr:outcomeId>B29205147B3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3398DE4-499F-4C94-8E43-4FC3154E4287</gtr:id><gtr:title>Exploration of the intercellular heterogeneity of topotecan uptake into human breast cancer cells through compartmental modelling.</gtr:title><gtr:parentPublicationTitle>Mathematical biosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7144b5ff2f4a15e645a966b00e1c58ce"><gtr:id>7144b5ff2f4a15e645a966b00e1c58ce</gtr:id><gtr:otherNames>Cheung SY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0025-5564</gtr:issn><gtr:outcomeId>79FD988EC7B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A495C8B-2230-46B2-9632-3F1183139BBA</gtr:id><gtr:title>Microwave-assisted synthesis of 5-aminopyrazol-4-yl ketones and the p38(MAPK) inhibitor RO3201195 for study in Werner syndrome cells.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b56f28666e97438b7e93beed50afe57"><gtr:id>3b56f28666e97438b7e93beed50afe57</gtr:id><gtr:otherNames>Bagley MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-894X</gtr:issn><gtr:outcomeId>A0CD67A859A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3CA5036-21A9-4F96-B040-FDA1A491B1A4</gtr:id><gtr:title>ABCG2-associated resistance to Hoechst 33342 and topotecan in a murine cell model with constitutive expression of side population characteristics.</gtr:title><gtr:parentPublicationTitle>Cytometry. Part A : the journal of the International Society for Analytical Cytology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/988a9bf4602ba26684ef8f41fe1b3fc6"><gtr:id>988a9bf4602ba26684ef8f41fe1b3fc6</gtr:id><gtr:otherNames>Smith PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1552-4922</gtr:issn><gtr:outcomeId>1B005B1A815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2A106A0-ED2D-4A0C-B328-F1FA58BB40B0</gtr:id><gtr:title>Expanded extracolonic tumor spectrum in MUTYH-associated polyposis.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8dd89b3ff86d9a585df3deec9df180d3"><gtr:id>8dd89b3ff86d9a585df3deec9df180d3</gtr:id><gtr:otherNames>Vogt S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>AB9AFE7A347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27349FC0-8559-48B3-B7E1-682F9FC3203F</gtr:id><gtr:title>Spectral analysis of the DNA targeting bisalkylaminoanthraquinone DRAQ5 in intact living cells.</gtr:title><gtr:parentPublicationTitle>Cytometry. Part A : the journal of the International Society for Analytical Cytology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13ef75b0bde3b4ab81a3c88108fa62f0"><gtr:id>13ef75b0bde3b4ab81a3c88108fa62f0</gtr:id><gtr:otherNames>Njoh KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1552-4922</gtr:issn><gtr:outcomeId>395F1000998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4F95889-2488-4B1F-BE9E-FC137A10C6F5</gtr:id><gtr:title>Poly(ADP-ribose) polymerase-1 inhibitor treatment regresses autochthonous Brca2/p53-mutant mammary tumors in vivo and delays tumor relapse in combination with carboplatin.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3949bf1334badf3a3eebed1458996c87"><gtr:id>3949bf1334badf3a3eebed1458996c87</gtr:id><gtr:otherNames>Hay T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>CMTUmfef9BM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54255605-8BA9-4B88-8A45-388AF2BFDD92</gtr:id><gtr:title>Tsc1 haploinsufficiency without mammalian target of rapamycin activation is sufficient for renal cyst formation in Tsc1+/- mice.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c690504953331fb806cb15021dc1c29b"><gtr:id>c690504953331fb806cb15021dc1c29b</gtr:id><gtr:otherNames>Wilson C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>C403770F131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC9EF53B-BE85-4283-9F89-A231DEBA266F</gtr:id><gtr:title>Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5f48968edfccea153a55bcc47ca6520"><gtr:id>e5f48968edfccea153a55bcc47ca6520</gtr:id><gtr:otherNames>Muncan V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>17809E0D4A5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C03447B-B306-4F52-AF0E-ACC06D7A3D78</gtr:id><gtr:title>Mechanisms of disease: methyl-binding domain proteins as potential therapeutic targets in cancer.</gtr:title><gtr:parentPublicationTitle>Nature clinical practice. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c29195d5b62c41ae4af17a583b36483"><gtr:id>1c29195d5b62c41ae4af17a583b36483</gtr:id><gtr:otherNames>Sansom OJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1743-4254</gtr:issn><gtr:outcomeId>96A3E214335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FCD2B19-8747-44F3-8839-6B80F4DB52B7</gtr:id><gtr:title>p21 loss blocks senescence following Apc loss and provokes tumourigenesis in the renal but not the intestinal epithelium.</gtr:title><gtr:parentPublicationTitle>EMBO molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10841b683e1f8da81abb22ed1c8a9c9e"><gtr:id>10841b683e1f8da81abb22ed1c8a9c9e</gtr:id><gtr:otherNames>Cole AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1757-4676</gtr:issn><gtr:outcomeId>oqypS7s2LLr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B471B938-0F0D-41ED-BBB7-4787386A0899</gtr:id><gtr:title>Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c782728a07ec423bd19af3c59d748e3"><gtr:id>2c782728a07ec423bd19af3c59d748e3</gtr:id><gtr:otherNames>Jones N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>D99AF23AF64</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4536C4A-B05D-4802-BAF6-B30ADB67B5F2</gtr:id><gtr:title>Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7b71591412aa3c7ac05af8226565c7d"><gtr:id>c7b71591412aa3c7ac05af8226565c7d</gtr:id><gtr:otherNames>Azzopardi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>EDAB6CFE38E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE5DCF37-8066-41B5-A447-59D1A8E9DFF7</gtr:id><gtr:title>The role of cellular senescence in Werner syndrome: toward therapeutic intervention in human premature aging.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e652d93fb2ebe4adce6078cb4fe2f70c"><gtr:id>e652d93fb2ebe4adce6078cb4fe2f70c</gtr:id><gtr:otherNames>Davis T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>48354CA0B33</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C13CFA55-BF64-49F5-A900-3473E16E6AC1</gtr:id><gtr:title>Mitotic bypass via an occult cell cycle phase following DNA topoisomerase II inhibition in p53 functional human tumor cells.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/988a9bf4602ba26684ef8f41fe1b3fc6"><gtr:id>988a9bf4602ba26684ef8f41fe1b3fc6</gtr:id><gtr:otherNames>Smith PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>DC272CED555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE48BBAD-EC34-4B57-A3DF-7A123080D4A0</gtr:id><gtr:title>Cyclin D2-cyclin-dependent kinase 4/6 is required for efficient proliferation and tumorigenesis following Apc loss.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10841b683e1f8da81abb22ed1c8a9c9e"><gtr:id>10841b683e1f8da81abb22ed1c8a9c9e</gtr:id><gtr:otherNames>Cole AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>cZR8z18XyPA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24D5386A-377E-432E-9411-69E8DC482B33</gtr:id><gtr:title>Technique for measurement of fluorescence lifetime by use of stroboscopic excitation and continuous-wave detection.</gtr:title><gtr:parentPublicationTitle>Applied optics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4902069ff96b68aa8581bfdd608d9ddd"><gtr:id>4902069ff96b68aa8581bfdd608d9ddd</gtr:id><gtr:otherNames>Matthews DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1559-128X</gtr:issn><gtr:outcomeId>75C94FDA413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B749D6A-AE47-4583-B041-33B7A7366C36</gtr:id><gtr:title>ProgeniDB: a novel cell lineage database for generation associated phenotypic behavior in cell-based assays.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e95a0e32d8c5f4b5b67078eac6f8deb"><gtr:id>9e95a0e32d8c5f4b5b67078eac6f8deb</gtr:id><gtr:otherNames>Khan IA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>0F62B4C7A6B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5FB918D-74D5-4B79-846E-85C2F3FF646D</gtr:id><gtr:title>Wnt signalling in the mouse intestine.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a815f035043115ade2a0578c8b56034e"><gtr:id>a815f035043115ade2a0578c8b56034e</gtr:id><gtr:otherNames>Clarke AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>674358E80CD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F3783A1-8810-4468-BAB2-55C1E1548213</gtr:id><gtr:title>Cell cycle checkpoint-guarded routes to catenation-induced chromosomal instability.</gtr:title><gtr:parentPublicationTitle>SEB experimental biology series</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/988a9bf4602ba26684ef8f41fe1b3fc6"><gtr:id>988a9bf4602ba26684ef8f41fe1b3fc6</gtr:id><gtr:otherNames>Smith PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1946-4959</gtr:issn><gtr:outcomeId>FAC926CDEC3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA0A1C1B-9D6E-4F9E-B1C0-B6655D2582C3</gtr:id><gtr:title>Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1691f1794b893fc588bac94db1e9e3b6"><gtr:id>1691f1794b893fc588bac94db1e9e3b6</gtr:id><gtr:otherNames>Gaspar C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>3D5F03BF169</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34A8D78F-7103-4FDE-92DC-2F468FAC8D21</gtr:id><gtr:title>Rapid synthesis of VX-745: p38 MAP kinase inhibition in Werner syndrome cells.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b56f28666e97438b7e93beed50afe57"><gtr:id>3b56f28666e97438b7e93beed50afe57</gtr:id><gtr:otherNames>Bagley MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0960-894X</gtr:issn><gtr:outcomeId>43E96CFF9D3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82EC7448-3345-40ED-81B3-F05A54102786</gtr:id><gtr:title>Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ebdef0231b3b333dca4bd2f5a87771d"><gtr:id>7ebdef0231b3b333dca4bd2f5a87771d</gtr:id><gtr:otherNames>Grindedal EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>E94DC62339F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F8A9D9E-8354-4C0B-9B1D-6EE13E1BBBA8</gtr:id><gtr:title>Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31152bac48c9c30ed7c2810018c35491"><gtr:id>31152bac48c9c30ed7c2810018c35491</gtr:id><gtr:otherNames>Dikovskaya D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>0583E0B38D0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98BB8C5C-EC21-4C71-8A59-D6BEC361E345</gtr:id><gtr:title>How chromatin is remodelled during DNA repair of UV-induced DNA damage in Saccharomyces cerevisiae.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59f2057fadd48aea99d995584a607c52"><gtr:id>59f2057fadd48aea99d995584a607c52</gtr:id><gtr:otherNames>Yu S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>Ju4xtNwJA7Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9378C64-6A7A-4BBB-927C-BB50598EBEEB</gtr:id><gtr:title>Chromosomal instability in MYH- and APC-mutant adenomatous polyps.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/baa167bd71d639fbc9dd8104a0a28db6"><gtr:id>baa167bd71d639fbc9dd8104a0a28db6</gtr:id><gtr:otherNames>Cardoso J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>E47104A1725</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60E4AEF7-A3B9-4B61-9AD8-7630404F6C45</gtr:id><gtr:title>CD200-expressing human basal cell carcinoma cells initiate tumor growth.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea90bdd0f7f8ae2987d6db040b73a061"><gtr:id>ea90bdd0f7f8ae2987d6db040b73a061</gtr:id><gtr:otherNames>Colmont CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15247_27_23292936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0730E3F-DE0D-421D-92D8-2DCA6C95551D</gtr:id><gtr:title>Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c29195d5b62c41ae4af17a583b36483"><gtr:id>1c29195d5b62c41ae4af17a583b36483</gtr:id><gtr:otherNames>Sansom OJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>BAA00DA8FC2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8411377F-CA98-4D0C-AA6B-F7B2883D73FB</gtr:id><gtr:title>Histone variant Htz1 promotes histone H3 acetylation to enhance nucleotide excision repair in Htz1 nucleosomes.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33f8b5eefa1739d60bdb71d6a13794da"><gtr:id>33f8b5eefa1739d60bdb71d6a13794da</gtr:id><gtr:otherNames>Yu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_15247_27_23925126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADF0713A-292D-435A-BDB3-A6617277D469</gtr:id><gtr:title>Normal stem cells in cancer prone epithelial tissues.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd8dab3c604a82336c7b97464f237af7"><gtr:id>dd8dab3c604a82336c7b97464f237af7</gtr:id><gtr:otherNames>Phesse TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>U8AD3GrdNEb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8D8F479-BA00-4D09-B133-2598DD7C4209</gtr:id><gtr:title>Aspirin activates the NF-kappaB signalling pathway and induces apoptosis in intestinal neoplasia in two in vivo models of human colorectal cancer.</gtr:title><gtr:parentPublicationTitle>Carcinogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/400c2f90b2c3893a1a4d059613a3c56b"><gtr:id>400c2f90b2c3893a1a4d059613a3c56b</gtr:id><gtr:otherNames>Stark LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0143-3334</gtr:issn><gtr:outcomeId>3ECC957E1E4</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0301154</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>